The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 5.1% since our last review. Ethical screening: PASS with ethical screening pending. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is momentum reading oversold. Over the past year the shares are down 36%. Our forward projection puts the odds of a 10% gain over the next month near 26%. The street (28 analysts) rates it strong buy, with a mean price target of $124.
BYD Company Limited
1211.HK · UNKNOWN · USD · Market cap $741.7B
BYD Company Limited, together with its subsidiaries, engages in automobiles and batteries business in the People's Republic of China, Hong Kong, Macau, Taiwan, and internationally.
PASS · Titan EthicalScreen close, 2026-09-22 · not a live quote
Last reviewed 14 days ago
Screened 2026-09-22 · the tape above runs as of 09:09 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
What this means: price 81.35 against the desk's fair-value range, base estimate 90.96, over the last year.
- Trend Markdown
- Insiders no filings inside 60 days, left as found
- Positioning no disclosures inside 60 days, left as found
- Options no verdict drawn today, left as found
- Ethical passes the values gate
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
This name holds its markdown label.
BYD Company Limited holds its Markdown at $81.35. The statistical read favours the sellers, held for 16 days.
| Phase | Markdown · caution |
| Quantitative state | The statistical read favours the sellers, held for 16 days |
| Price at the screen | $81.35 |
| Valuation | 21.69 trailing · 12.51 forward price to earnings |
| Values screen | PASS |
| Beta | 0.33 |
Five Screens, Shown in Full
Full pass across all five screens. This security clears the Titan Ethical Standard: its business and its balance sheet both stay inside the lines.
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Permissible | Core business clean | Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. | Pass |
| Debt load | 13.48% | Below 33% | Interest-bearing debt is just 13.5% of its assets, well under the one-third ceiling: it does not run on borrowed money. | Pass |
| Interest-bearing cash | 1.32% | Below 33% | Cash held in interest-bearing accounts and securities is 1.3% of assets, under the one-third limit. | Pass |
| Receivables | 12.72% | Below 49% | Money owed to the company is 12.7% of assets, under the 49% limit. | Pass |
| Revenue purity | 0.30% | Below 5% | Only 0.3% of revenue comes from non-compliant sources, under the 5% line. | Pass |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical ReadWhy It Clears, in Plain English
BYD clears all five screens. Its business is in a permissible area, its interest-bearing debt is about 13%, inside the ~33% line, and almost none of its income is interest, so it passes.
Read as at 2026-10-04. It updates when the underlying figures move, and past reads are kept below.
What the Numbers Say It Is WorthThe Fair Value Range
Fair value range in USD, drawn from the 2026-09-22 screen. The gold marker is the market price at the same screen. A 11.8% margin of safety to the base estimate.
Third-party analyst targets: 27 covering, consensus Strong Buy. The average target sits +56% from the screen price.
Reading the gap · Both our model and the analysts see meaningful upside from here.
Price History & ProjectionsWhere it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-09-22 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words| Forward P/E | 12.5xreasonably valued |
| Trailing P/E | 21.7xa premium valuation |
| EPS, trailing | 3.77 |
| EPS, forward | 6.47 |
| Revenue growth | -3.2%revenue is shrinking |
| Profit margin | 3.8%barely profitable |
| Return on equity | 11.6%a modest return on shareholder capital |
| FCF yield | -12.98% |
| Debt to equity | 0.46minimal debt: a conservative balance sheet |
| Current ratio | 0.87below 1: short-term bills exceed liquid assets |
| Beta | 0.33barely tracks the market's swings |
| 52-week range | 71.40 - 114.70 |
| Moat | MODERATE |
| Market cap | $741.7B |
The risks · The things to watch: its business and earnings are exposed to China and to currency swings.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade1211.HK trades on UNKNOWN (the company is based in China). As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 4.8% since our last review. Ethical screening: PASS with ethical screening pending. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading oversold. Over the past year the shares are down 36%. Our forward projection puts the odds of a 10% gain over the next month near 26%. The street (28 analysts) rates it strong buy, with a mean price target of $124.
The framework has shifted from distribution to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved up 1.5% since our last review. Ethical screening: PASS with ethical screening pending. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is momentum reading oversold. Over the past year the shares are down 36%. Our forward projection puts the odds of a 10% gain over the next month near 26%. The street (28 analysts) rates it strong buy, with a mean price target of $124.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved up 0.7% since our last review. Ethical screening: PASS with ethical screening pending. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is momentum reading oversold. Over the past year the shares are down 36%. Our forward projection puts the odds of a 10% gain over the next month near 26%. The street (28 analysts) rates it strong buy, with a mean price target of $124.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with ethical screening pending. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is momentum reading oversold. Over the past year the shares are down 36%. Our forward projection puts the odds of a 10% gain over the next month near 26%. The street (28 analysts) rates it strong buy, with a mean price target of $124.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with ethical screening pending. The risk-adjusted return profile shows good risk-adjusted returns.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with ethical screening pending. The risk-adjusted return profile shows good risk-adjusted returns.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Ethical screening: PASS with ethical screening pending. The risk-adjusted return profile shows good risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
- Peter Schiff Says ‘High-Quality’ Chinese Vehicles Sold in Panama Cost Half as Much as Comparable Models in US, Blames Tariffs: ‘Americans Pay More…’ Benzinga · 8d ago
- Tesla's Biggest Semi Deal Yet: Is TSLA Stock a Buy Now? Zacks · 12d ago
- Tesla’s EU Registrations Jump Nearly 53% In August – But Chinese EV Rivals Grow Much Faster Stocktwits · 12d ago
- Volkswagen opens presales of second Xpeng joint model in China Reuters · 12d ago
- Tesla Makes Brilliant Supercharger Move but BYD Is Closer in the Mirror Than It Appears Motley Fool · 12d ago
Headlines from third-party outlets, linked for reference: not our reporting, not advice.
Screened names in the same industry · explore each on its own page.
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $101.22 | -14.9% | $0.41 | $856 | -14.4% |
| 2 months | $104.60 | -17.6% | $0.41 | $828 | -17.2% |
| 3 months | $97.73 | -11.8% | $0.41 | $886 | -11.4% |
| 6 months | $98.03 | -12.1% | $0.41 | $883 | -11.7% |
| 1 year | $134.96 | -36.1% | $1.86 | $652 | -34.8% |
| 2 years | $73.69 | +17.0% | $2.99 | $1,210 | +21.0% |
| 3 years | $80.79 | +6.7% | $3.41 | $1,109 | +10.9% |
| 5 years | $68.93 | +25.0% | $3.45 | $1,300 | +30.0% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever 1211.HK does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.